Geldenhuys, Werner
- West Virginia University · Pharmacology (NIH department code)
- Modulation Therapeutics, Inc. (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #11,715
- R01 Holder
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2017 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Pharmacology
NIH Funding · FY2023
Linked Award Amount
$894.5K
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#11,715
By linked amount among FY2023 PIs
Earliest Year Loaded
2017
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Geldenhuys, Werner as a PI. Multi-PI records show the full award amount for context.
- 1R01NS129998-01A1R01Contact PImitoNEET as a therapeutic target for mitigating ischemic brain injury following MCAOWest Virginia University · Pharmacology (NIH department code)$549.5Kaward amount
- 1R41DK131705-01A1R41Contact PIMTI-301 a SCD1 inhibitor for the treatment of NASH$344.9Kaward amount
Award organizations
Organizations that administered FY2023 awards listing Geldenhuys, Werner as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2017First NIH AwardWest Virginia University
- 2018$500K Cumulative Funding
- 2018$1M Cumulative Funding
- 2018Entered Top 50% NationallyRanked #5855
- 2018Multi-Institutional ResearchAwards at 2 institutions
- 2018R01 Grant Holder
- 2023$2M Cumulative Funding